Sign In
Buy DXCM
$72.59
-0.180 (-0.247%)
At Close: Jun 04, 2026
DexCom Inc Is Being Sued For Possible Securities Fraud And The Schall Law Firm Encourages Affected Investors To Help
11:00am, Saturday, 28'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "t
DXCM Deadline to Lead in Securities Fraud Lawsuit is October 21, 2024 – Contact Kaplan Fox & Kilsheimer LLP
07:00pm, Friday, 27'th Sep 2024
Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM) securities between January 8, 2024 and July 25, 2024 (th
Contact Levi & Korsinsky by October 21, 2024 Deadline to Join Class Action Against DexCom, Inc. (DXCM)
03:30pm, Friday, 27'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ:DXCM) and certain of the Co
NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 2
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM
12:00pm, Friday, 27'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM
11:30am, Friday, 27'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM). Such investors are a
Shareholders That Lost Money on DexCom, Inc. (DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
11:15am, Friday, 27'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
Stockholders Are Urged By The Schall Law Firm To Take Part In A Case Against DexCom, Inc. For Securities Law Violations
11:00am, Friday, 27'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "t
Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - DXCM
08:30am, Friday, 27'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
DexCom (DXCM) Accused of Misleading Investors About Sales Force Changes and Financial Outlook - Hagens Berman
08:08am, Friday, 27'th Sep 2024
SAN FRANCISCO, Sept. 27, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM), alleging that the medical device company made misleading statements about i
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
NEW YORK CITY, NY / ACCESSWIRE / September 27, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
